- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02142855
Structural and Metabolic Determinants of Sarcopenia and the Efficacy of Concentric vs. Eccentric Exercise Training
October 27, 2017 updated by: University of Nottingham
Structural and Metabolic Determinants of Sarcopenia and the Efficacy of Concentric vs. Eccentric Exercise Training: a Novel Temporospatial Approach
The first goal of this study is the follow young and older people over a period of 8 weeks to define the processes responsible for loss of muscle length and width in age-related muscle wasting (sarcopenia) and allow us to look at age-related differences in tendon.
Secondly, we will assess two different exercise interventions for reversing human sarcopenia; one which involves shortening of the muscle and the other which involves lengthening, whilst also studying why these exercises work the way they do.
This project will have significant implications for our understanding of the control of skeletal muscle and tendon size in humans, particularly in relation to sarcopenia and the surrounding health issues.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Derbyshire
-
Derby, Derbyshire, United Kingdom, DE22 3DT
- University of Nottingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Healthy male volunteers
- Body mass index 18-30 kg/m2
- Aged 18-35 and 65-75 years
Exclusion Criteria:
- Participation in a formal exercise regime,
- A BMI < 18 or > 30 kg/m2,
- Active cardiovascular disease,
- Taking beta-adrenergic blocking agents, statins or non-steroidal anti-inflammatory drugs,
- Cerebrovascular disease,
- Respiratory disease,
- Metabolic disease,
- Active inflammatory bowel or renal disease,
- Malignancy,
- Recent steroid treatment (within 6 months) or hormone replacement therapy,
- Clotting dysfunction,
- Musculoskeletal or neurological disorders,
- Family history of early (<55y) death from cardiovascular disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Old Control
Older individuals (65-75 y) with no exercise intervention
|
|
|
Experimental: Old Concentric
Older individuals (65-75 y) studied before and after 8 weeks concentric exercise training
|
8 weeks concentric exercise training, 3 x per week, 60% 1-RM; 4 x 12-15 repetitions, 2 min rest between sets
|
|
Experimental: Old Eccentric
Older individuals (65-75 y) studied before and after 8 weeks eccentric exercise training
|
8 weeks eccentric exercise training, 3 x per week, 60% 1-RM; 4 x 12-15 repetitions, 2 min rest between sets
|
|
No Intervention: Young Control
Young individuals (18-30 y) with no exercise intervention
|
|
|
Experimental: Young Concentric
Young individuals (18-30 y) studied before and after 8 weeks concentric exercise training
|
8 weeks concentric exercise training, 3 x per week, 60% 1-RM; 4 x 12-15 repetitions, 2 min rest between sets
|
|
Experimental: Young Eccentric
Young individuals (18-30 y) studied before and after 8 weeks eccentric exercise training
|
8 weeks eccentric exercise training, 3 x per week, 60% 1-RM; 4 x 12-15 repetitions, 2 min rest between sets
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle protein synthesis
Time Frame: 0 - 8 weeks
|
Comparison of muscle protein synthesis using D2O in young and older individuals and in response to 8 weeks concentric or eccentric exercise training
|
0 - 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tendon protein synthesis
Time Frame: 0 - 8 weeks
|
Comparison of tendon protein synthesis in young and older individuals and in response to 8 weeks concentric or eccentric exercise training
|
0 - 8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle function
Time Frame: 0 - 8 weeks
|
Muscle strength, force and power in young and older individuals and in response to 8 weeks concentric or eccentric exercise training
|
0 - 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Marco V Narici, PhD, University of Nottingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2014
Primary Completion (Actual)
May 1, 2017
Study Completion (Actual)
May 1, 2017
Study Registration Dates
First Submitted
May 16, 2014
First Submitted That Met QC Criteria
May 19, 2014
First Posted (Estimate)
May 20, 2014
Study Record Updates
Last Update Posted (Actual)
October 30, 2017
Last Update Submitted That Met QC Criteria
October 27, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B13032014 SoMSGEM BBSRC3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.